United Therapeutics Corp. (UTHR)
541.70
-29.68
(-5.19%)
USD |
NASDAQ |
Oct 02, 16:00
537.12
-4.58
(-0.85%)
After-Hours: 20:00
United Therapeutics Price : 541.70 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 570.00 | 577.02 | 541.27 | 541.70 | 1.118M |
| Oct 01, 2026 | 557.53 | 585.79 | 556.76 | 571.38 | 1.691M |
| Sep 30, 2026 | 482.20 | 557.37 | 475.46 | 541.89 | 3.337M |
| Sep 29, 2026 | 485.54 | 487.62 | 471.34 | 481.47 | 439866.0 |
| Sep 28, 2026 | 473.84 | 486.98 | 470.76 | 485.54 | 628267.0 |
| Sep 25, 2026 | 474.04 | 479.97 | 470.40 | 475.45 | 472446.0 |
| Sep 24, 2026 | 472.72 | 481.32 | 468.97 | 472.21 | 585525.0 |
| Sep 23, 2026 | 498.82 | 500.05 | 487.73 | 489.42 | 433400.0 |
| Sep 22, 2026 | 493.98 | 499.58 | 488.08 | 497.59 | 586402.0 |
| Sep 21, 2026 | 497.70 | 497.70 | 491.26 | 493.10 | 1.186M |
| Sep 18, 2026 | 498.07 | 499.23 | 492.57 | 494.63 | 1.501M |
| Sep 17, 2026 | 501.49 | 503.32 | 492.59 | 497.27 | 1.454M |
| Sep 16, 2026 | 500.62 | 505.78 | 497.66 | 498.48 | 488401.0 |
| Sep 15, 2026 | 505.44 | 507.15 | 498.85 | 500.35 | 1.605M |
| Sep 14, 2026 | 506.78 | 509.06 | 499.62 | 502.70 | 605734.0 |
| Sep 11, 2026 | 505.60 | 508.68 | 496.18 | 497.11 | 573361.0 |
| Sep 10, 2026 | 502.44 | 509.79 | 497.91 | 503.86 | 653160.0 |
| Sep 09, 2026 | 502.75 | 509.52 | 492.90 | 506.82 | 500106.0 |
| Sep 08, 2026 | 494.74 | 505.00 | 479.71 | 497.97 | 643544.0 |
| Sep 04, 2026 | 484.33 | 494.08 | 484.33 | 487.61 | 327025.0 |
| Sep 03, 2026 | 494.09 | 494.09 | 477.06 | 490.24 | 469577.0 |
| Sep 02, 2026 | 510.00 | 510.05 | 477.01 | 492.02 | 1.404M |
| Sep 01, 2026 | 514.20 | 517.75 | 510.39 | 512.70 | 478996.0 |
| Aug 31, 2026 | 510.95 | 515.55 | 507.03 | 510.38 | 538523.0 |
| Aug 28, 2026 | 527.94 | 530.50 | 513.72 | 515.46 | 266870.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Liquidia Corp. | 28.64 |
| MannKind Corp. | 3.80 |
| Insmed, Inc. | 111.12 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
Price Related Metrics
| PE Ratio | 19.38 |
| PS Ratio | 8.054 |
| PEG Ratio | 2.115 |
| Price to Book Value | 3.612 |
| Price to Free Cash Flow | 23.43 |
| Earnings Yield | 5.16% |
| Market Cap | 23.12B |
| PEGY Ratio | 2.115 |
| Operating PE Ratio | 18.10 |
| Normalized PE Ratio | 20.76 |